Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa.
about
Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'IvoireCost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalNon-vertical HIV transmission to children in sub-Saharan Africa.Overestimates of survival after HAART: implications for global scale-up effortsValidation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil.Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya.Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.A simple novel method for determining mortality rates in HIV treatment programs worldwide.A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adultsScaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West AfricaRetention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya.Comparison of methods to correct survival estimates and survival regression analysis on a large HIV African cohort.An observational cohort comparison of facilitators of retention in care and adherence to anti-eetroviral therapy at an HIV treatment center in Kenya.Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South Africa.The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire."Wamepotea" (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya.Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'IvoireAIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'IvoireA clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment.The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHODEstimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy.Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West AfricaInsurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies.Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme.Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.Electronic medical records and same day patient tracing improves clinic efficiency and adherence to appointments in a community based HIV/AIDS care program, in Uganda.Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program.CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa.Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.CD4+ T-lymphocytes natural decrease in HAART-naïve HIV-infected adults in Abidjan.Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia.A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.
P2860
Q28475790-BC5107F2-2D88-46CD-9362-BFDA92590A48Q28476337-A80024C1-E00A-4D6B-9054-D6DBBDE506E9Q30383040-0A4C3086-06F0-4158-9ABB-A6F1600E5450Q33322531-C4166F64-CE53-49C3-9F30-DFFCB823F612Q33375306-BB0BFBDD-6E64-43BE-812E-6DD9BBC76194Q33388709-20BA57A6-5A9D-4DEE-A9E3-9F471D2A599DQ33619740-F9C0F620-5F9C-4232-AA27-02B1EE3C867BQ33803701-F6901CB5-AF76-4C52-8476-4B700A95CBA0Q33803726-6143306B-353E-4571-ABBD-7CE2F05EB144Q33864631-66F3DABC-3191-452C-B66A-9DB0D1590A9AQ33965572-E109B64E-43BB-49CC-9F41-69EA6468FE13Q34056735-FCD995B4-E2DB-4FCA-B3BE-606451FA55B8Q34088780-3895401F-2CD4-4254-BAE2-AE2EABD2841BQ34181897-289CA191-4345-4182-8769-413D254DE6BFQ34199982-A4D8636B-1E61-4175-9220-3707143B5535Q34495138-2CA03B0D-F8F0-4172-AEBA-506375ACA22CQ34539445-922DCA0D-6871-43CE-9F8B-E6414EB5F1A0Q34777433-2B7DC201-6CB4-4517-837A-517EAC9FF978Q35134482-9258BDE4-B7FB-4BF0-8CF5-7DDD782C285CQ35190245-627A5C3A-5C91-4160-872F-AD830BAB193FQ35745688-D8D06999-3C59-4713-8CF5-A4562D57ED9AQ35814967-83D597A4-C596-4A05-90FF-BF16583344DDQ35916153-34923B39-4233-45C8-9E6C-6A2C01A97620Q36440576-E60CF2B7-256A-4208-9149-DE2C8D338422Q36565583-678B34C0-C350-405B-B3AE-5C2413898D89Q36712377-F9E32447-967C-4A7E-9BCE-6A5ED6CB1C34Q36793768-71CF1C42-E74F-4295-BD4D-07C8B1D34965Q36919443-1F37EB28-C4CA-43EE-AAAF-17321B147F82Q36936569-7AFB4497-215C-4A1F-B775-0CAA5F22880BQ37265947-F3169BAA-587E-4CEE-A890-70217CFCCFB2Q37412384-E111A9D2-9509-4CAA-B568-820E810DB2E2Q37412402-509A3F13-2493-4F13-90BD-56372AD5EB1BQ37578941-D06BEACA-B4BD-404C-9222-FFA18663B36CQ37578947-497243DC-E330-4EC4-84CD-E588D6EBAC75Q38906079-E8F1C46A-6D4E-400E-93F0-EA44FB86287BQ39678239-DCA61A30-CC3D-472F-ABA2-25E9A7B925ADQ46679607-77E3B0C1-9FF6-4F54-A63E-5CB54F7BC9EEQ46909093-D8665EDA-5B21-4A85-865E-50516F4FC5FAQ54919188-07BFA08F-1BE6-4F70-A4E2-B1C1AA22F8DF
P2860
Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Impact of vital status investi ...... ients from Sub-Saharan Africa.
@en
type
label
Impact of vital status investi ...... ients from Sub-Saharan Africa.
@en
prefLabel
Impact of vital status investi ...... ients from Sub-Saharan Africa.
@en
P2093
P1476
Impact of vital status investi ...... ients from Sub-Saharan Africa.
@en
P2093
Amah Tchehy
Catherine Seyler
Gwénola Gourvellec
Hélène Coulibaly
Jean Lehou
Lambert Zio
Marcel Zaho
Marie-Cécile Kassi
Roger Salamon
Siaka Toure
P304
P356
10.1097/00126334-200403010-00015
P407
P577
2004-03-01T00:00:00Z